FindTrial
Sign In

Impact of eNOS gene and ACE gene polymorhisms on the response to salvianolate injection in Chinese Han patients with coronary heart disease

Impact of eNOS gene and ACE gene polymorhisms on the response to salvianolate injection in Chinese Han patients with coronary heart disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RCC-12002895
Enrollment
Unknown
Registered
2012-12-26
Start date
2011-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Control group:no
coronary heart disease:no

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: patients with coronary heart disease, Healthy individuals.

Exclusion criteria

Exclusion criteria: patients with non-coronary heart disease; Non-healthy individuals.

Design outcomes

Primary

MeasureTime frame
dosage of of nitroglycerin;—

Contacts

Public ContactZhao-Qian Liu
liuzhaoqian63@126.com+86 13787797720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026